"Telomerase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An essential ribonucleoprotein reverse transcriptase that adds telomeric DNA to the ends of eukaryotic CHROMOSOMES.
Descriptor ID |
D019098
|
MeSH Number(s) |
D08.811.913.696.445.308.300.750.750 D12.776.157.687.613 D12.776.157.725.500.921 D12.776.660.720.613 D12.776.664.962.500.921
|
Concept/Terms |
Telomerase- Telomerase
- Telomerase Reverse Transcriptase
- Reverse Transcriptase, Telomerase
- Transcriptase, Telomerase Reverse
Telomerase Catalytic Subunit- Telomerase Catalytic Subunit
- Catalytic Subunit, Telomerase
- Subunit, Telomerase Catalytic
- Telomerase Reverse Transcriptase Catalytic Subunit
|
Below are MeSH descriptors whose meaning is more general than "Telomerase".
Below are MeSH descriptors whose meaning is more specific than "Telomerase".
This graph shows the total number of publications written about "Telomerase" by people in this website by year, and whether "Telomerase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 2 | 0 | 2 |
2009 | 1 | 0 | 1 |
2013 | 1 | 0 | 1 |
2014 | 0 | 1 | 1 |
2017 | 10 | 6 | 16 |
2018 | 2 | 7 | 9 |
2019 | 9 | 1 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Telomerase" by people in Profiles.
-
RNA-dependent RNA polymerase, RdRP, a promising therapeutic target for cancer and potentially COVID-19. Cancer Sci. 2020 Nov; 111(11):3976-3984.
-
Are changes in telomerase activity and telomere length due to different exercise modalities, intensity, or methods: intermittency? Eur Heart J. 2019 10 07; 40(38):3198-3199.
-
Response to: Jiménez-Pavon et al. and Patanè. Eur Heart J. 2019 10 07; 40(38):3201.
-
Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis. Pathol Oncol Res. 2020 Jul; 26(3):1573-1582.
-
Prognostic significance of human telomerase reverse transcriptase promoter region mutations C228T and C250T for overall survival in spinal chordomas. Neuro Oncol. 2019 08 05; 21(8):1005-1015.
-
Coexistence of BRAF V600E and TERT Promoter Mutations in Low-grade Serous Carcinoma of Ovary Recurring as Carcinosarcoma in a Lymph Node: Report of a Case. Int J Gynecol Pathol. 2019 Jul; 38(4):386-392.
-
Suppression of c-Myc using 10058-F4 exerts caspase-3-dependent apoptosis and intensifies the antileukemic effect of vincristine in pre-B acute lymphoblastic leukemia cells. J Cell Biochem. 2019 08; 120(8):14004-14016.
-
Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma. Int J Mol Sci. 2019 Mar 16; 20(6).
-
PFKFB2 Promoter Hypomethylation as Recurrence Predictive Marker in Well-Differentiated Thyroid Carcinomas. Int J Mol Sci. 2019 Mar 16; 20(6).
-
Contributory role of microRNAs in anti-cancer effects of small molecule inhibitor of telomerase (BIBR1532) on acute promyelocytic leukemia cell line. Eur J Pharmacol. 2019 Mar 05; 846:49-62.